Cargando…
Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
Objectives. We evaluated the ingestibility and formulation quality of one branded (formulation A) and five generic (formulations B, C, D, E, and F) lansoprazole orally disintegrating (OD) tablets. Methods. Ingestibility, including the oral disintegrating time, taste, mouth feeling, and palatability,...
Autores principales: | Chono, Sumio, Matsui, Megumi, Nakamura, Katsuki, Kasai, Ryoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156814/ https://www.ncbi.nlm.nih.gov/pubmed/28044122 http://dx.doi.org/10.1155/2016/6131608 |
Ejemplares similares
-
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
por: Kukulka, Michael, et al.
Publicado: (2016) -
Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet
por: Hesari, Zahra, et al.
Publicado: (2016) -
Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022) -
Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives
por: Ghourichay, Mohammadali Poursharifi, et al.
Publicado: (2021) -
Predicting oral disintegrating tablet formulations by neural network techniques
por: Han, Run, et al.
Publicado: (2018)